Pharma Focus Asia

Ferring Announces US$30 million Expansion Plan of New Biotech Centre in Switzerland


Ferring Pharmaceuticals made a US$30 million investment announcement of expanding its capabilities in biologics through a new biotech centre at its global headquarters and manufacturing site in St Prex, Switzerland.


Ferring Pharmaceuticals is planning to integrate discovery and development capabilities for monoclonal antibodies as well as biologics manufacturing capabilities at its new biotech center in Switzerland.

The manufacturing capabilities of the company will include API - Active Pharmaceutical Ingredient for follitropin delta along with latest fertility treatment.

Ferring Pharma Company is committed to investing in innovative technology platforms to create new solutions for patients in the core areas of reproductive medicine, women’s health, gastroenterology, and urology.

The company’s expansion investment in state-of-the-art manufacturing and development technologies will get completed by next three years.

Ferring had announced a tie-up with Ligand Pharmaceuticals to use Ligand’s OmniAb platform to explore new human monoclonal antibodies in order to fulfill the patient needs in urology, gastroenterology, and other reproductive medicines.


NameFerring Pharmaceuticals
LocationSt. Prex, Switzerland
Estimated BudgetUS$30 million
Parties InvolvedFerring Pharmaceuticals, Ligand Pharmaceuticals
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?